ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Fluoride Study Update Finds No Increased Risk

October 19, 1990

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

DCCP Board Oks Fur New Concepts

July 17, 1981